Ohio State Navbar

Carson Named Associate Director of OSUCCC for Clinical Research


COLUMBUS, Ohio – An oncologist with special interest in immunology has been named associate director for clinical research for The Ohio State University Comprehensive Cancer Center (OSUCCC).

William Carson III, MD></td>         </tr> <tr>            <td>       <div align=
William Carson III, MD
Dr. William Carson III (43026) is co-leader of the Immunology Program in the OSUCCC and a surgeon in the Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

As associate director for clinical research for the OSUCCC, Carson will supervise and help coordinate the efforts of over 200 scientists and physicians in 13 colleges across The Ohio State University Campus who have as their common goal the development of new strategies for the prevention and treatment of cancer through clinical trial investigation.

Carson joined Ohio State in 1997 and is currently an associate professor in the departments of surgery and molecular virology, immunology and medical genetics. He was recently chosen to lead the Ohio State University Medical Center’s new cancer-centered Institutional Review Board.

A graduate of the University of California, Carson received his medical degree from the University of Southern California in 1986. He served his residency at the University of California Irvine Medical Center and then moved to Buffalo, New York, where he assumed research and surgical fellowships at the Roswell Park Cancer Institute.

Carson, who is specifically interested in the development of immune-based strategies for treating cancer, holds over one million dollars in research grants from the National Cancer Institute. His studies focus on the use of interferons in the treatment of malignant melanoma, the use of immune system hormones as adjuvants for monoclonal antibodies, angiogenesis in solid tumors, and stress and immunity in breast cancer.

He is the author of over 40 peer-reviewed articles in prestigious scientific journals including the Journal of Experimental Medicine, Journal of Clinical Investigation, Blood and the Proceedings of the National Academy of Sciences. Carson is a peer reviewer for the U. S. Department of Defense Breast Cancer Research and Prostate Cancer Programs. He is a member of the editorial board of the journal Cancer Immunology and Immunotherapy and journal referee for over a dozen other publications, including the Journal of Clinical Oncology, Cancer Research and Blood.

The Ohio State University Comprehensive Cancer Center (OSUCCC) is a network of interdisciplinary research programs comprising over 200 investigators in 13 colleges and the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute on the OSU campus. OSUCCC members conduct research on the prevention, detection, diagnosis and treatment of cancer, generating over $75 million annually in external funding.

# # #